Rituximab as First-Line Therapy in Severe Lupus Erythematosus with Neuropsychiatric and Renal Involvement: A Case-Report and Review of the Literature

Neuropsychiatric and renal involvement are common in systemic lupus erythematosus with negative impact on patient survival. Glucocorticoids, antiproliferative and cytotoxic agents represent first-line therapies, but are often ineffective and are burdened by significant toxicities. Despite the negati...

Descripción completa

Detalles Bibliográficos
Autores principales: Angeletti, Andrea, Baraldi, Olga, Chiocchini, Anna Laura, Comai, Giorgia, Cravedi, Paolo, La Manna, Gaetano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991483/
https://www.ncbi.nlm.nih.gov/pubmed/29888753
http://dx.doi.org/10.4172/2165-7920.10001033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991483/
https://www.ncbi.nlm.nih.gov/pubmed/29888753
http://dx.doi.org/10.4172/2165-7920.10001033

Ejemplares similares